Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...
Upcoming safety data release expected to also highlight favorable tolerability profile observed to date and ease-of-use of the regimen that includes cyclophosphamide/fludarabine conditioning, and ...
Findings point to importance of RSV vaccination in older patients with systemic autoimmune rheumatic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback